Xtant Medical Inc.
XTNT | AMEX
$0.48
-$0.02 (-4.84%)
At close: May 13, 2026, 3:59 PM ET
Market Data
Market Cap $70.65M
Enterprise Value $78.94M
Beta -0.12
Average Volume 149.85K
Shares Outstanding (Diluted) 150.46M
Shares Change YoY 8.26%
Institutional Ownership 58.43%
Exchange AMEX
ISIN US98420P3082
Price Performance
Price Change 1M 0.1%
Price Change 3M -17.7%
Price Change 6M -26.4%
Price Change YTD -35.7%
Price Change 1Y -19.5%
Price Change 3Y -24.9%
Price Change 5Y -66.7%
1M CAGR (ann.) -7.1%
1Y CAGR (ann.) -0.1%
5Y CAGR (ann.) -21.5%
All-Time CAGR -34.5%
Valuation
PE Ratio 14.33
Forward PE 145.75
PEG Ratio 0.01
Forward PEG N/A
PS Ratio 0.50
Forward PS 0.60
PB Ratio 1.32
P/FCF Ratio 6.62
P/Adj. FCF Ratio 8.50
P/OCF Ratio 5.33
EV/Sales 0.59
EV/EBIT 7.40
EV/EBITDA 4.97
EV/FCF 7.77
Earnings Yield 7.0%
FCF Yield 15.1%
Adj. FCF Yield 11.8%
Financial Health
Net Debt $8.33M
Total Debt $28.72M
Cash & Short-Term Investments $17.05M
Total Assets $94.15M
Current Ratio 2.65
Quick Ratio 1.63
Debt / Equity Ratio 0.56
Debt / EBITDA 1.81
Debt / FCF 2.83
OCF / Debt 0.44
Interest Coverage 1.98
Altman Z-Score -0.38
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 62.9%
Operating Profit Margin 5.4%
EBITDA Margin 11.9%
Net Profit Margin 3.7%
FCF Margin 7.6%
Adj. FCF Margin 5.9%
SBC / Revenue 1.7%
SBC Impact (per share) -22.1%
Returns
Return on Assets 5.3%
Return on Equity 10.3%
Return on Invested Capital 6.5%
Return on Capital Employed 11.3%
Return on Tangible Assets 5.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 32.2%
Revenue CAGR 5Y 20.2%
Revenue CAGR 10Y 8.5%
EPS CAGR 3Y 44.4%
EPS CAGR 5Y 22.4%
EPS CAGR 10Y 10.1%
FCF CAGR 3Y 81.0%
FCF CAGR 5Y 109.3%
FCF CAGR 10Y 18.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y -2.0%
Earnings Date May 12, 2026
EPS Estimate (next Q) -$0.01
EPS Growth Est (next Q) -3850.0%
Revenue Est (next Q) $20.16M
Revenue Growth Est (next Q) -38.7%
Fair Value Estimates
Graham Number $0.52
Graham Upside 8.3%
Lynch Fair Value $0.67
Lynch Upside 39.6%
Price Target $1.50
Price Target Upside 212.5%
Cash Flow
Operating Cash Flow $12.55M
Free Cash Flow $10.16M
Adj. Free Cash Flow $7.91M
FCF Per Share $0.07
OCF Per Share $0.09
OCF/S Ratio 9.4%
Income Statement
Revenue $133.93M
Gross Profit $84.27M
Operating Income $7.28M
EBITDA $15.9M
Net Income $4.97M
EPS (Diluted) $0.03
Revenue / Employee $617.18K
Profit / Employee $22.92K
Employees 217
Add to Watchlist
Select watchlists to add or remove XTNT